Time of Growth

It’s an exciting time to be a member of the Alkermes team. The pace is fast, the environment is dynamic and the ideas are inspired. The reward of helping to make a difference in the lives of millions of people encourages a culture of compassion and awareness. If you are interested in contributing to our team and helping us reach our goals, please take a look at our current job openings.


Why CNS?

Alkermes is advancing the latest science to develop new medicines for central nervous system (CNS) diseases. Our drug development approach is grounded not only in science, but also in deep understanding of the real-world needs of patients and healthcare providers. As an innovator in chronic CNS diseases, we apply new scientific insights and use advanced technologies. Our results to date include a pipeline of drug candidates in schizophrenia, major depressive disorder and multiple sclerosis that are moving forward in clinical development on the path to reaching millions of patients who struggle with these chronic diseases.

Alkermes’ research and development in the CNS field is founded on proven science and deep experience. All told, working independently and in partnership with others, we have helped to develop more than 20 medications approved to treat serious medical conditions.

We have made strong achievements in the field of CNS, but there are many more opportunities ahead. Alkermes will continue to deploy our unique perspective when it comes to developing CNS medications — our belief is that slight progress is not enough. We’re committed to finding treatment solutions that will make a meaningful difference for patients and their families, as well as with making a positive impact for healthcare systems and society.